Proactiveinvestors USA & Canada Propanc Biopharma, Inc. https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Propanc Biopharma, Inc. RSS feed en Wed, 11 Dec 2019 03:53:50 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Propanc Biopharma nears production of synthetic pancreatic proenzymes https://ca.proactiveinvestors.com/companies/news/907299/propanc-biopharma-nears-production-of-synthetic-pancreatic-proenzymes-907299.html Mon, 18 Nov 2019 17:25:00 -0500 https://ca.proactiveinvestors.com/companies/news/907299/propanc-biopharma-nears-production-of-synthetic-pancreatic-proenzymes-907299.html Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP https://ca.proactiveinvestors.com/companies/news/905255/propanc-biopharma-plans-to-advance-clinical-trials-on-lead-cancer-drug-prp-905255.html Mon, 21 Oct 2019 14:13:00 -0400 https://ca.proactiveinvestors.com/companies/news/905255/propanc-biopharma-plans-to-advance-clinical-trials-on-lead-cancer-drug-prp-905255.html Propanc Biopharma wins US patent to better protect its lead cancer-fighting drug PRP https://ca.proactiveinvestors.com/companies/news/901244/propanc-biopharma-wins-us-patent-to-better-protect-its-lead-cancer-fighting-drug-prp-901244.html Wed, 21 Aug 2019 17:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/901244/propanc-biopharma-wins-us-patent-to-better-protect-its-lead-cancer-fighting-drug-prp-901244.html Propanc Biopharma publishes promising study of its metastatic cancer drug in peer-reviewed medical journal https://ca.proactiveinvestors.com/companies/news/900549/propanc-biopharma-publishes-promising-study-of-its-metastatic-cancer-drug-in-peer-reviewed-medical-journal-900549.html Mon, 12 Aug 2019 15:24:00 -0400 https://ca.proactiveinvestors.com/companies/news/900549/propanc-biopharma-publishes-promising-study-of-its-metastatic-cancer-drug-in-peer-reviewed-medical-journal-900549.html Propanc looks to history to capitalize on glimmering angle in cancer treatment https://ca.proactiveinvestors.com/companies/news/218617/propanc-looks-to-history-to-capitalize-on-glimmering-angle-in-cancer-treatment-218617.html Thu, 08 Aug 2019 19:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/218617/propanc-looks-to-history-to-capitalize-on-glimmering-angle-in-cancer-treatment-218617.html Propanc Biopharma moves closer to first-in-human study by quantifying ingredients for its metastatic cancer drug https://ca.proactiveinvestors.com/companies/news/900391/propanc-biopharma-moves-closer-to-first-in-human-study-by-quantifying-ingredients-for-its-metastatic-cancer-drug-900391.html Thu, 08 Aug 2019 18:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/900391/propanc-biopharma-moves-closer-to-first-in-human-study-by-quantifying-ingredients-for-its-metastatic-cancer-drug-900391.html Propanc Biopharma gears up to file clinical trial application for its lead anti-cancer therapy PRP https://ca.proactiveinvestors.com/companies/news/223927/propanc-biopharma-gears-up-to-file-clinical-trial-application-for-its-lead-anti-cancer-therapy-prp-223927.html Mon, 15 Jul 2019 17:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/223927/propanc-biopharma-gears-up-to-file-clinical-trial-application-for-its-lead-anti-cancer-therapy-prp-223927.html Propanc Biopharma boosts its patent portfolio for its anti-cancer therapy https://ca.proactiveinvestors.com/companies/news/313926/propanc-biopharma-boosts-its-patent-portfolio-for-its-anti-cancer-therapy-13926.html Fri, 28 Jun 2019 19:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/313926/propanc-biopharma-boosts-its-patent-portfolio-for-its-anti-cancer-therapy-13926.html Propanc poised to unlock shareholder value as it boosts its patent portfolio for cancer-fighting drugs https://ca.proactiveinvestors.com/companies/news/222986/propanc-poised-to-unlock-shareholder-value-as-it-boosts-its-patent-portfolio-for-cancer-fighting-drugs-222986.html Thu, 27 Jun 2019 16:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/222986/propanc-poised-to-unlock-shareholder-value-as-it-boosts-its-patent-portfolio-for-cancer-fighting-drugs-222986.html Propanc Biopharma taps longtime advisor as chief financial officer https://ca.proactiveinvestors.com/companies/news/222685/propanc-biopharma-taps-longtime-advisor-as-chief-financial-officer-222685.html Mon, 24 Jun 2019 13:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/222685/propanc-biopharma-taps-longtime-advisor-as-chief-financial-officer-222685.html Propanc Biopharma appoints Ralf Brandt to scientific advisory board as it develops cancer patent https://ca.proactiveinvestors.com/companies/news/313357/propanc-biopharma-appoints-ralf-brandt-to-scientific-advisory-board-as-it-develops-cancer-patent-13357.html Wed, 15 May 2019 05:54:00 -0400 https://ca.proactiveinvestors.com/companies/news/313357/propanc-biopharma-appoints-ralf-brandt-to-scientific-advisory-board-as-it-develops-cancer-patent-13357.html Propanc welcomes founding member back to scientific advisory board https://ca.proactiveinvestors.com/companies/news/219722/propanc-welcomes-founding-member-back-to-scientific-advisory-board-219722.html Mon, 06 May 2019 13:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/219722/propanc-welcomes-founding-member-back-to-scientific-advisory-board-219722.html Propanc CEO looks to harness power of pancreatic enzymes in cancer fight https://ca.proactiveinvestors.com/companies/news/218971/propanc-ceo-looks-to-harness-power-of-pancreatic-enzymes-in-cancer-fight-218971.html Tue, 23 Apr 2019 14:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/218971/propanc-ceo-looks-to-harness-power-of-pancreatic-enzymes-in-cancer-fight-218971.html Propanc at final stages of completing manufacturing steps to file first clinical trial application https://ca.proactiveinvestors.com/companies/news/312236/propanc-at-final-stages-of-completing-manufacturing-steps-to-file-first-clinical-trial-application-12236.html Thu, 14 Feb 2019 19:39:00 -0500 https://ca.proactiveinvestors.com/companies/news/312236/propanc-at-final-stages-of-completing-manufacturing-steps-to-file-first-clinical-trial-application-12236.html